Paulo Gustavo Kotze (P G Kotze, Paulo G Kotze)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 42

Top Topics

Mesenchymal Stem Cells

Psychometric Properties

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Top Venues

Therapeutic advances in gastroenterology

Alimentary pharmacology & therapeutics

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pauline Riviere, Gabriele Bislenghi, Nassim Hammoudi, Bram Verstockt, Steven Brown, Melissa Oliveira-Cunha, Willem Bemelman, Gianluca Pellino, Paulo Gustavo Kotze, null null, Marc Ferrante, Yves Panis
Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and risk factors of postoperative Crohn's disease recurrence after an ileocolic resection. Journal of Crohn's & colitis (2023)
Letícia Rodrigues de Souza, Daniela Oliveira Magro, Fábio Vieira Teixeira, Rogério Serafim Parra, Eron Fábio Miranda, Omar Féres, Rogério Saad-Hossne, Giedre Soares Prates Herrerias, Renato Mitsunori Nisihara, Claudio Saddy Rodrigues Coy, Ligia Yukie Sassaki, Paulo Gustavo Kotze
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study. Pharmaceutics 15 (2) (2023)
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Sameer Al Awadhi, Axel U Dignass, Ailsa L Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Ferdinando D'Amico, Fernando Magro, Benedicte Caron, Axel U Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis. Journal of clinical medicine 12 (3) (2023)
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Sameer Al Awadhi, Axel U Dignass, Ailsa L Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Natália Souza Freitas Queiroz, Camilla de Almeida Martins, Abel Botelho Quaresma, Pablo A Olivera Sendra, Kenneth Ernest-Suarez, Paulo Gustavo Kotze
IBD barriers across the continents: a continent-specific analysis: Latin America. Therapeutic advances in gastroenterology 16 (2023)
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Sameer Al Awadhi, Axel U Dignass, Ailsa L Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Natália Souza Freitas Queiroz, Camilla de Almeida Martins, Abel Botelho Quaresma, Pablo A Olivera Sendra, Kenneth Ernest-Suarez, Paulo Gustavo Kotze
IBD barriers across the continents: a continent-specific analysis: Latin America. Therapeutic advances in gastroenterology 16 (2023)
David T Rubin, Leonardo Salese, Mitchell Cohen, Paulo Gustavo Kotze, John C Woolcott, Chinyu Su, Rajiv Mundayat, Jerome Paulissen, Joana Torres, Millie D Long
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program. Therapeutic advances in gastroenterology 16 (2023)
Ferdinando D'Amico, Fernando Magro, Benedicte Caron, Axel U Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis. Journal of clinical medicine 12 (3) (2023)
Letícia Rodrigues de Souza, Daniela Oliveira Magro, Fábio Vieira Teixeira, Rogério Serafim Parra, Eron Fábio Miranda, Omar Féres, Rogério Saad-Hossne, Giedre Soares Prates Herrerias, Renato Mitsunori Nisihara, Claudio Saddy Rodrigues Coy, Ligia Yukie Sassaki, Paulo Gustavo Kotze
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study. Pharmaceutics 15 (2) (2023)
Bénédicte Caron, Vipul Jairath, Ferdinando D'Amico, Sameer Al Awadhi, Axel U Dignass, Ailsa L Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Letícia Rodrigues de Souza, Daniela Oliveira Magro, Fábio Vieira Teixeira, Rogério Serafim Parra, Eron Fábio Miranda, Omar Féres, Rogério Saad-Hossne, Giedre Soares Prates Herrerias, Renato Mitsunori Nisihara, Claudio Saddy Rodrigues Coy, Ligia Yukie Sassaki, Paulo Gustavo Kotze
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study. Pharmaceutics 15 (2) (2023)
Ferdinando D'Amico, Virginia Solitano, Fernando Magro, Pablo Andres Olivera, Jonas Halfvarson, David T Rubin, Axel Dignass, Sameer Al Awadhi, Taku Kobayashi, Natália Souza Freitas Queiroz, Marta Calvo, Paulo Gustavo Kotze, Subrata Ghosh, Laurent Peyrin-Biroulet, Silvio Danese
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus. Journal of clinical medicine 12 (19) (2023)
Ferdinando D'Amico, Fernando Magro, Benedicte Caron, Axel U Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis. Journal of clinical medicine 12 (3) (2023)
Letícia Rodrigues de Souza, Daniela Oliveira Magro, Fábio Vieira Teixeira, Rogério Serafim Parra, Eron Fábio Miranda, Omar Féres, Rogério Saad-Hossne, Giedre Soares Prates Herrerias, Renato Mitsunori Nisihara, Claudio Saddy Rodrigues Coy, Ligia Yukie Sassaki, Paulo Gustavo Kotze
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study. Pharmaceutics 15 (2) (2023)
Shaji Sebastian, Jonathan P Segal, Charlotte Rose Hedin, Gianluca Pellino, Paulo Gustavo Kotze, Michel Adamina, Marjo J E Campmans-Kuijpers, Justin Davies, Annemarie C de Vries, Ana Gutiérrez Casbas, Alaa El-Hussuna, Pascal Juillerat, Susanna Meade, Monica Millán, Antonino Spinelli
ECCO Topical Review: Roadmap to optimal peri-operative care in IBD. Journal of Crohn's & colitis (2022)
Paula Cenira Senger de Castro, Daniela Oliveira Magro, Rodrigo Bremer Nones, Thaísa Kowalski Furlan, Eron Fábio Miranda, Paulo Gustavo Kotze
USTEKINUMAB IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN OBSERVATIONAL STUDY. Arquivos de gastroenterologia (2022)
Maria Paula Carlini Cambi, Takayuki Yamamoto, Paulo Gustavo Kotze
Importance of Nutrition and Hypoalbuminaemia in Postoperative Morbidity in Crohn's Disease: Thinking Outside of the Box on Biologics as Single Risk Factors. Journal of Crohn's & colitis 15 (8) (2021)
Fernanda da Silva Barbosa Baraúna, Paulo Gustavo Kotze
CORRELATION BETWEEN TROUGH LEVELS OF INFLIXIMAB AND POSTOPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE PATIENTS SUBMITTED TO ILEOCOLONIC RESECTIONS: A SYSTEMATIC REVIEW. Arquivos de gastroenterologia 58 (1) (2021)
Francis A Farraye, Taha Qazi, Paulo Gustavo Kotze, Gregory T Moore, Rajiv Mundayat, Nervin Lawendy, Puza P Sharma, Donna T Judd
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme. Alimentary pharmacology & therapeutics 54 (4) (2021)
Rodrigo Bremer Nones, Phillip R Fleshner, Natália Souza Freitas Queiroz, Adam S Cheifetz, Antonino Spinelli, Silvio Danese, Laurent Peyrin-Biroulet, Konstantinos Papamichael, Paulo Gustavo Kotze
Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical Patient. Journal of clinical medicine 10 (23) (2021)
Abel Botelho Quaresma, Fernanda da Silva Barbosa Baraúna, Fábio Vieira Teixeira, Rogério Saad Hossne, Paulo Gustavo Kotze
Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review. Journal of clinical medicine 10 (4) (2021)
David T Rubin, Walter Reinisch, Thomas Greuter, Paulo Gustavo Kotze, Marcia Pinheiro, Rajiv Mundayat, Eric Maller, Marc Fellmann, Nervin Lawendy, Irene Modesto, Stephan R Vavricka, Gary R Lichtenstein
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. Therapeutic advances in gastroenterology 14 (2021)
Pablo A Olivera, Stéphane Zuily, Paulo Gustavo Kotze, Veronique Regnault, Sameer Al Awadhi, Peter Bossuyt, Richard B Gearry, Subrata Ghosh, Taku Kobayashi, Patrick Lacolley, Edouard Louis, Fernando Magro, William K K Wu, Alfredo Papa, Timothy Raine, Fabio V Teixeira, David T Rubin, Silvio Danese, Laurent Peyrin Biroulet
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nature reviews. Gastroenterology & hepatology 18 (12) (2021)
Abel Botelho Quaresma, Takayuki Yamamoto, Paulo Gustavo Kotze
Biologics and surgical outcomes in Crohn's disease: is there a direct relationship? Therapeutic advances in gastroenterology 13 (2020)
Paulo Gustavo Kotze, Fábio Vieira Teixeira, Aderson Omar Mourão Cintra Damião
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Alimentary pharmacology & therapeutics 51 (11) (2020)
Takayuki Yamamoto, Paulo Gustavo Kotze
Letter: should we delay surgery, or stop anti-TNF therapy prior to elective surgical procedures in Crohn's disease patients receiving anti-TNF agents? Alimentary pharmacology & therapeutics 50 (8) (2020)
Paulo Gustavo Kotze, Flavio Steinwurz, Carlos Francisconi, Cyrla Zaltman, Marcia Pinheiro, Leonardo Salese, Dario Ponce de Leon
Review of the epidemiology and burden of ulcerative colitis in Latin America. Therapeutic advances in gastroenterology 13 (2020)
Abel Botelho Quaresma, Paulo Gustavo Kotze
Reduction of surgical rates in inflammatory bowel diseases biologic era: Similarities between Spain and Latin America. Journal of gastroenterology and hepatology 35 (8) (2020)
Sangmin Lee, Megan Crowe, Cynthia H-T Seow, Paulo Gustavo Kotze, Gilaad G Kaplan, Amy Metcalfe, Amanda Ricciuto, Eric I Benchimol, M Ellen Kuenzig
Surgery for Inflammatory Bowel Disease Has Unclear Impact on Female Fertility: A Cochrane Collaboration Systematic Review. Journal of the Canadian Association of Gastroenterology 4 (3) (2020)
Takayuki Yamamoto, Takahiro Shimoyama, Paulo Gustavo Kotze
Letter: is measurement of faecal biomarkers helpful for the early diagnosis and prediction of pouchitis after proctocolectomy for ulcerative colitis? Alimentary pharmacology & therapeutics 51 (1) (2020)
Marjorie Costa Argollo, Paulo Gustavo Kotze, Pradeep Kakkadasam, Geert D'Haens
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? Nature reviews. Gastroenterology & hepatology 17 (11) (2020)
Fábio Vieira Teixeira, Rogério Serafim Parra, Omar FÉres, Paulo Gustavo Kotze
Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies? Clinics (Sao Paulo, Brazil) 74 (2019)
Takayuki Yamamoto, Paulo Gustavo Kotze
Letter: can a specific surgical approach reduce post-operative recurrence in Crohn's disease? Alimentary pharmacology & therapeutics 48 (9) (2019)
Ronaldo Parisi Buanaim, Deivid Ramos Dos Santos, Lívia Guerreiro de Barros Bentes, Paulo Gustavo Kotze, Eduardo Felipe Kim Goto, Roberta Lais Mendonça de Mattos, Victor Matheus Mendonça de Araújo, Carlos Augusto Real Martinez
Effects of anti-TNF-α in experimental diversion colitis. Acta cirurgica brasileira 34 (10) (2019)
C Ma, Paulo Gustavo Kotze
Editorial: biologic therapies for primary sclerosing cholangitis-more disappointment than promise? Alimentary pharmacology & therapeutics 48 (5) (2019)
Michele Carvello, Amy Lightner, Takayuki Yamamoto, Paulo Gustavo Kotze, Antonino Spinelli
Mesenchymal Stem Cells for Perianal Crohn's Disease. Cells 8 (7) (2019)
Paulo Gustavo Kotze, Christopher Ma, Nicholas Mckenna, Abdulelah Almutairdi, Gilaad G Kaplan, Laura E Raffals, Edward V Loftus, Remo Panaccione, Amy L Lightner
Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis. Therapeutic advances in gastroenterology 11 (2018)
Paulo Gustavo Kotze, Bo Shen, Amy Lightner, Takayuki Yamamoto, Antonino Spinelli, Subrata Ghosh, Remo Panaccione
Modern management of perianal fistulas in Crohn's disease: future directions. Gut 67 (6) (2018)
Paulo Gustavo Kotze, Christopher Ma, Abdulelah Almutairdi, Ahmed Al-Darmaki, Shane M Devlin, Gilaad G Kaplan, Cynthia H-T Seow, Kerri L Novak, Cathy Lu, Jose G P Ferraz, Michael J Stewart, Michelle Buresi, Humberto Jijon, Meena Mathivanan, Joan Heatherington, Marie-Louise Martin, Remo Panaccione
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease. Alimentary pharmacology & therapeutics 48 (6) (2018)
Paulo Gustavo Kotze, Daniela Oliveira Magro, Carlos Augusto Real Martinez, Antonino Spinelli, Takayuki Yamamoto, Janindra Warusavitarne, Claudio Saddy Rodrigues Coy
Long Time from Diagnosis to Surgery May Increase Postoperative Complication Rates in Elective CD Intestinal Resections: An Observational Study. Gastroenterology research and practice 2018 (2018)